Lenzings, High-Stakes

Lenzing's High-Stakes Balancing Act: Doubled Profits Meet a €300m Dilution Hurdle

Published on 08/06/2026 at 17:45 | Redaktion boerse-global.de

Lenzing's H1 net profit doubled to €35.6M, but shares fell 4.5% as investors eye a €300M rights issue and restructuring costs.

Lenzing's €300M Capital Raise: Net Profit Doubles, Shares Fall on Dilution Fears
Lenzing's High-Stakes Balancing Act: Doubled Profits Meet a €300m Dilution Hurdle Illustration mit AI erstellt übermittelt durch boerse-global.de

The arithmetic of Lenzing's latest chapter is deceptively simple on paper: net profit doubled, yet the share price fell. But the Austrian fibre specialist's half-year results, published on Wednesday, were never really about the earnings line — they were a prelude to a far more consequential event scheduled for 25 August, when shareholders will vote on a capital increase of up to €300 million.

That vote explains the market's initial coolness. Despite net profit climbing to €35.6 million from €15.2 million a year earlier, the stock shed roughly 4.5 percent on the day of the announcement, closing at €23.60. Thursday brought a more measured reassessment, with shares trading at €24.30, up 2.97 percent in intraday trading — a sign that investors were beginning to weigh the operational improvements against the looming dilution.

A Shrinking Top Line, By Design

The headline revenue figure tells only part of the story. First-half sales fell to €1.27 billion from €1.34 billion, a decline the company frames not as weakness but as deliberate strategy. Lenzing has been retreating from low-margin standard textile fibres, a portfolio cleanup that is also reshaping its physical footprint. Production at the Heiligenkreuz site in Austria is slated to end by late 2026, followed by the Grimsby facility in the UK by the end of 2027.

The operational metrics underneath that shrinking top line offer some reassurance. EBITDA reached €239.2 million in the first half, while free cash flow improved to €45.8 million from €43.1 million a year earlier — modest progress, but notable for a group mid-restructuring. The transformation carries costs, however: management expects non-cash impairments of up to €150 million this year, tied to the site consolidations, and has announced the elimination of roughly 2,000 full-time positions globally by 2030.

Should investors sell immediately? Or is it worth buying Lenzing?

The €300m Question

The centrepiece of the turnaround is the fully underwritten rights issue, designed to fortify the balance sheet over the long term. Core shareholders have signalled their commitment in unambiguous terms: B&C Gruppe and Suzano S.A. have irrevocably agreed to participate pro rata through a syndicate, committing approximately €156.7 million between them, with Oberbank adding up to €11.6 million. The package is rounded out by new credit facilities of up to €300 million and an extension of existing liabilities through 2030.

Management has paired the financing with concrete targets: an EBITDA margin between 20 and 25 percent and a leverage ratio below 2.5x. The strategic direction, announced under the banner "Grow Nonwovens, Reset Textiles," is equally explicit — the nonwovens segment is the designated growth engine, while the traditional textile fibre business is being deliberately wound down. The divestment of the Indonesian subsidiary PT South Pacific Viscose is already underway as part of the same portfolio pruning.

Leadership and the Long View

The restructuring is being steered by new leadership. Georg Kasperkovitz took over as chief executive on 1 June, succeeding Stephan Sielaff, and is tasked with driving the operational overhaul and sharpening the focus on nonwovens.

Lenzing at a turning point? This analysis reveals what investors need to know now.

The market's caution is understandable. The stock remains 18.32 percent below its 52-week high of €29.75, reached in June, and trades 1.85 percent under its 200-day moving average. A capital increase of up to €300 million will visibly alter the shareholder structure, even with loyal core investors on board — the kind of dilution that tends to weigh on sentiment regardless of the strategic rationale.

Until the extraordinary general meeting delivers its verdict, the shares are likely to oscillate between two competing narratives: solid operational progress on one hand, impending dilution on the other. The next data point after the vote arrives on 5 November, when third-quarter figures are due. Whether Lenzing's painful reset proves the right prescription for a European fibre producer navigating structural industry change will only become clear in the months ahead.

Ad

Lenzing Stock: New Analysis - 6 August

Fresh Lenzing information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Lenzing analysis...

Disclaimer...

en | AT0000644505 | LENZINGS | boerse | 69923398 |